Rabma 40 Tablet
Marketer
Thelma Lifesciences
Salt Composition
Rabeprazole (40mg)
Overview Rabma 40 Tablet
Gastric acid production is reduced by the medication, Acilin 40mg Tablet. It treats stomach and intestinal conditions stemming from excess acid, including acid reflux, peptic ulcers, and Zollinger-Ellison syndrome. The tablet alleviates symptoms and fosters healing. Acilin 40mg should be ingested one hour prior to meals, ideally in the morning. Dosage is determined by your condition and response. Consistent daily dosing, as directed by your physician, is crucial, even if symptoms subside rapidly. Managing symptoms can be aided by smaller, more frequent meals, and eschewing caffeinated beverages, spicy foods, and fatty foods. Common, typically mild, side effects include nausea, vomiting, headache, dizziness, gas, diarrhea, and stomach ache. Report persistent or bothersome side effects to your doctor. Prolonged use (over a year) may elevate fracture risk, particularly at higher dosages. Discuss bone loss prevention strategies, such as calcium and vitamin D supplements, with your doctor. Low magnesium (hypomagnesemia) has been observed in patients using this medication for three months or longer, potentially causing fatigue, confusion, dizziness, muscle spasms, and irregular heartbeat. Your doctor may monitor your magnesium levels. Acilin 40mg is unsuitable for some individuals. Inform your doctor of severe liver disease, HIV medication use, prior allergic reactions to similar drugs, or existing osteoporosis before commencing treatment. Pregnant or breastfeeding women should seek medical advice. Alcohol consumption should be avoided due to its acid-increasing effect. Refrain from operating machinery or driving if dizziness or drowsiness occurs.
Uses of Rabma 40 Tablet
Managing gastroesophageal reflux, peptic ulcers, and Zollinger-Ellison syndrome.
Major Benefits of Rabma 40 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Rabma 40 Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication on an empty stomach.
Common Side effects of Rabma 40 Tablet:
- Diarrhea
- Dizziness
- Flatulence
- Headache
- Nausea
- Sore throat
- Stomach pain
- Vomiting
How to use Rabma 40 Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Rabma 40 Tablet should be administered on an empty stomach.
How Rabma 40 Tablet works:
Rabma 40 Tablet, a proton pump inhibitor (PPI), lessens stomach acid production, providing relief from heartburn and acid indigestion.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when combining Rabma 40 Tablet and alcohol. Seek medical advice before doing so.
PregnancyCONSULT YOUR DOCTOR
The use of Rabma 40 Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Use of Rabma 40 Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking Rabma 40 Tablet might reduce attentiveness, impair vision, and cause drowsiness or dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
Rabma 40 Tablets pose no safety concerns for patients with kidney disease and require no dosage modification.
LiverSAFE IF PRESCRIBED
Rabma 40 Tablet poses no safety concerns for individuals with hepatic impairment. No modification of the Rabma 40 Tablet dosage is necessary.
What if you forget to take Rabma 40 Tablet :
Should you forget a Rabma 40 Tablet dose, administer it promptly. However, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Rabma 40 Tablet
| Label | Value |
|---|---|
| Chemical Category | Benzimidazole Sulfoxide |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Actions | PPIs (proton pump inhibitors) |



